[Ala107]MBP (104-118) (acetate)

[Ala107]MBP (104-118) acetate is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM[1].

Product Specifications

UNSPSC

12352209

Target

PKC

Related Pathways

Epigenetics; TGF-beta/Smad

Field of Research

Others

Smiles

O=C(N[C@@H](CCCCN)C(NCC(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CO)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(NCC(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN.CC(O)=O.[x]

Molecular Formula

C67H104N20O19.xC2H4O2

Molecular Weight

1493.67 (free base)

References & Citations

[1]Su HD, et, al. Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C) . Biochem Biophys Res Commun. 1986 Jan 14; 134 (1) : 78-84.